Kanawha Capital Management LLC lowered its holdings in CarMax, Inc. (NYSE:KMX – Free Report) by 49.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,282 shares of the company’s stock after selling 4,263 shares during the period. Kanawha Capital Management LLC’s holdings in CarMax were worth $331,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Private Advisor Group LLC grew its stake in shares of CarMax by 83.2% in the first quarter. Private Advisor Group LLC now owns 21,032 shares of the company’s stock valued at $1,832,000 after buying an additional 9,549 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in shares of CarMax by 45.8% in the 1st quarter. BNP Paribas Financial Markets now owns 185,692 shares of the company’s stock worth $16,176,000 after acquiring an additional 58,290 shares during the period. Janney Montgomery Scott LLC increased its position in shares of CarMax by 1.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 27,448 shares of the company’s stock valued at $2,391,000 after purchasing an additional 342 shares during the period. Tokio Marine Asset Management Co. Ltd. boosted its position in shares of CarMax by 11.6% during the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,721 shares of the company’s stock valued at $498,000 after purchasing an additional 594 shares in the last quarter. Finally, Nordea Investment Management AB increased its holdings in shares of CarMax by 6.6% in the first quarter. Nordea Investment Management AB now owns 13,378 shares of the company’s stock valued at $1,166,000 after buying an additional 831 shares in the last quarter.
CarMax Stock Performance
Shares of NYSE:KMX opened at $73.06 on Tuesday. The business has a fifty day moving average of $76.59 and a 200-day moving average of $74.96. The company has a debt-to-equity ratio of 2.93, a quick ratio of 0.68 and a current ratio of 2.25. CarMax, Inc. has a twelve month low of $61.73 and a twelve month high of $88.22. The firm has a market cap of $11.32 billion, a PE ratio of 27.47, a price-to-earnings-growth ratio of 1.47 and a beta of 1.68.
Analyst Upgrades and Downgrades
KMX has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. boosted their price target on shares of CarMax from $55.00 to $65.00 and gave the company an “underweight” rating in a report on Thursday, September 19th. StockNews.com upgraded CarMax to a “sell” rating in a report on Friday, July 26th. Needham & Company LLC reaffirmed a “buy” rating and issued a $90.00 price target on shares of CarMax in a research report on Wednesday, October 16th. Evercore ISI lifted their price objective on CarMax from $76.00 to $79.00 and gave the stock an “in-line” rating in a report on Thursday, October 17th. Finally, BNP Paribas upgraded shares of CarMax to a “strong sell” rating in a research report on Friday, September 27th. Four investment analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $79.73.
Read Our Latest Research Report on KMX
About CarMax
CarMax, Inc, through its subsidiaries, operates as a retailer of used vehicles and related products in the United States. It operates in two segments: CarMax Sales Operations and CarMax Auto Finance. The CarMax Sales Operations segment offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; used vehicle auctions; extended protection plans to customers at the time of sale; and reconditioning and vehicle repair services.
Recommended Stories
- Five stocks we like better than CarMax
- Stock Average Calculator
- Intel: Is Now the Time to Be Brave?Â
- What Are Dividend Achievers? An Introduction
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for CarMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CarMax and related companies with MarketBeat.com's FREE daily email newsletter.